Amlacher R, Härtl A, Neubert R, Stöckel U, Wenzel K
Zentralinstitut für Mikrobiologie and Experimentelle Therapie, Jena, Germany.
J Pharm Pharmacol. 1991 Nov;43(11):794-7. doi: 10.1111/j.2042-7158.1991.tb03484.x.
The simultaneous i.v. administration of equimolar doses of bretylium and hexylsalicylic acid results in an increase in plasma area under the curve value of both substances in comparison with their separate administration. The higher plasma levels of both compounds were associated with a reduced renal excretion and an increased biliary elimination. However, the increase in biliary excretion did not compensate for the reduced elimination of bretylium and hexylsalicylic acid via the kidney. The results presented in this paper give further evidence that ion-pairing in-vivo may result in altered pharmacokinetics of drugs particularly due to changes in biliary or renal excretion.
与分别给药相比,同时静脉注射等摩尔剂量的溴苄铵和己基水杨酸会导致两种物质的血浆曲线下面积值增加。两种化合物较高的血浆水平与肾脏排泄减少和胆汁排泄增加有关。然而,胆汁排泄的增加并不能弥补溴苄铵和己基水杨酸经肾脏排泄的减少。本文给出的结果进一步证明,体内离子配对可能会导致药物药代动力学发生改变,特别是由于胆汁或肾脏排泄的变化。